{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:46:04Z","timestamp":1792809964647,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Radiation-induced coronary artery disease (R-CAD) has become an increasingly recognized phenomenon. Although the clinical relationship between radiation therapy and CAD risk is well known, there is minimal investigation of the gender relationship to radiation-induced CAD events and the\u00a0resulting cardiovascular (CV) events\/mortality. We study the gender variation in the incidence of CV events\/mortality related to R-CAD in Hodgkin\u2019s Lymphoma (HL) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The Preferred Reporting Items for Systematic Reviews and Meta-Analyses\u00a0(PRISMA) guidelines were used in this systematic review and network meta-analysis. OVID, Cochrane Central Register of Controlled Trials via the Wiley Interface, Web of Science Core Collection, MEDLINE, EMBASE, and Google Scholar were investigated to identify prospective and retrospective observational studies comparing women and men following radiation treatment for Hodgkin\u2019s lymphoma. Ten studies were included (4 prospective, 6 retrospective). The primary outcome was incidence of cardiovascular events\/mortality. The secondary outcome was all-cause mortality. Meta-regression for age was also performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 13,975 patients, including 41% females and 59% males, CV events\/mortality were noted to be significantly higher in women compared to men (OR 3.74, 95% CI 2.44\u20135.72,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u20090.001). All-cause mortality was also higher in women compared to men (OR 1.94, 95% CI 1.10\u20133.44,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u20090.023). On meta-regression analysis, elderly populations have a higher rate of mortality, which was even higher for women than men (coefficient\u2009=\u20090.0458,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.0374).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Women have a higher rate of R-CAD related CV events\/mortality and all-cause mortality compared to men amongst\u00a0radiation-treated patients. These data highlight the need for increased surveillance to better monitor for R-CAD in female patients treated with mantle or mediastinal radiation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40959-020-00067-7","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T05:03:02Z","timestamp":1596603782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Gender disparity in cardiovascular mortality following radiation therapy for Hodgkin\u2019s lymphoma: a systematic review"],"prefix":"10.1186","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1210-3977","authenticated-orcid":false,"given":"Yaser","family":"Khalid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neethi","family":"Dasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirti","family":"Dasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,5]]},"reference":[{"issue":"20","key":"67_CR1","first-page":"1647","volume":"104","author":"JR Cuomo","year":"2018","unstructured":"Cuomo JR, Javaheri SP, Sharma GK, Kapoor D, Berman AE, Weintraub NL. How to prevent and manage radiation-induced coronary artery disease. Heart Br Card Soc. 2018;104(20):1647\u201353.","journal-title":"Heart Br Card Soc."},{"issue":"2","key":"67_CR2","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1182\/blood-2010-06-291328","volume":"117","author":"SL Galper","year":"2011","unstructured":"Galper SL, Yu JB, Mauch PM, Strasser JF, Silver B, LaCasce A, et al. Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood. 2011;117(2):412\u20138.","journal-title":"Blood."},{"issue":"6","key":"67_CR3","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","volume":"175","author":"FA van Nimwegen","year":"2015","unstructured":"van Nimwegen FA, Schaapveld M, Janus CPM, Krol ADG, Petersen EJ, Raemaekers JMM, et al. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk. JAMA Intern Med. 2015;175(6):1007.","journal-title":"JAMA Intern Med."},{"issue":"3","key":"67_CR4","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.radonc.2013.10.029","volume":"110","author":"T Wethal","year":"2014","unstructured":"Wethal T, Nedregaard B, Andersen R, Foss\u00e5 A, Lund MB, G\u00fcnther A, et al. Atherosclerotic lesions in lymphoma survivors treated with radiotherapy. Radiother Oncol. 2014;110(3):448\u201354.","journal-title":"Radiother Oncol."},{"issue":"24","key":"67_CR5","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1056\/NEJMoa022628","volume":"348","author":"BMP Aleman","year":"2003","unstructured":"Aleman BMP, Raemaekers JMM, Tirelli U, Bortolus R, van \u2018t Veer MB, Lybeert MLM, et al. Involved-field radiotherapy for advanced Hodgkin\u2019s lymphoma. N Engl J Med. 2003;348(24):2396\u2013406.","journal-title":"N Engl J Med"},{"issue":"7","key":"67_CR6","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-08-3392","volume":"107","author":"EC Moser","year":"2006","unstructured":"Moser EC. Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma. Blood. 2006;107(7):2912\u20139.","journal-title":"Blood."},{"issue":"8","key":"67_CR7","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1002\/ijc.24147","volume":"124","author":"A Andersson","year":"2009","unstructured":"Andersson A, N\u00e4slund U, Tavelin B, Enblad G, Gustavsson A, Malmer B. Long-term risk of cardiovascular disease in Hodgkin lymphoma survivors-retrospective cohort analyses and a concept for prospective intervention. Int J Cancer. 2009;124(8):1914\u20137.","journal-title":"Int J Cancer."},{"issue":"13","key":"67_CR8","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1182\/blood-2010-01-263764","volume":"116","author":"S Myrehaug","year":"2010","unstructured":"Myrehaug S, Pintilie M, Yun L, Crump M, Tsang RW, Meyer RM, et al. A population-based study of cardiac morbidity among Hodgkin lymphoma patients with preexisting heart disease. Blood. 2010;116(13):2237\u201340.","journal-title":"Blood."},{"issue":"11","key":"67_CR9","doi-asserted-by":"publisher","first-page":"e492","DOI":"10.1016\/S2352-3026(15)00153-2","volume":"2","author":"MV Maraldo","year":"2015","unstructured":"Maraldo MV, Giusti F, Vogelius IR, Lundemann M, van der Kaaij MAE, Ramadan S, et al. Cardiovascular disease after treatment for Hodgkin\u2019s lymphoma: an analysis of nine collaborative EORTC-LYSA trials. Lancet Haematol. 2015;2(11):e492\u2013502.","journal-title":"Lancet Haematol."},{"issue":"21","key":"67_CR10","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1001\/jama.290.21.2831","volume":"290","author":"MC Hull","year":"2003","unstructured":"Hull MC, Morris CG, Pepine CJ, Mendenhall NP. Valvular Dysfunction and Carotid, Subclavian, and Coronary Artery Disease in Survivors of Hodgkin Lymphoma Treated With Radiation Therapy. JAMA. 2003;290(21):2831.  https:\/\/doi.org\/10.1186\/s40959-020-00067-7.","journal-title":"JAMA."},{"issue":"12","key":"67_CR11","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/sim.791","volume":"20","author":"J Hartung","year":"2001","unstructured":"Hartung J, Knapp G. On tests of the overall treatment effect in meta-analysis with normally distributed responses. Stat Med. 2001;20(12):1771\u201382.","journal-title":"Stat Med."},{"issue":"24","key":"67_CR12","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1002\/sim.1009","volume":"20","author":"J Hartung","year":"2001","unstructured":"Hartung J, Knapp G. A refined method for the meta-analysis of controlled clinical trials with binary outcome. Stat Med. 2001;20(24):3875\u201389.","journal-title":"Stat Med."},{"issue":"21","key":"67_CR13","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1002\/sim.1262","volume":"21","author":"K Sidik","year":"2002","unstructured":"Sidik K, Jonkman JN. A simple confidence interval for meta-analysis. Stat Med. 2002;21(21):3153\u20139.","journal-title":"Stat Med."},{"issue":"303","key":"67_CR14","first-page":"690","volume":"58","author":"N Mantel","year":"1963","unstructured":"Mantel N. Chi-Square tests with one degree of freedom; extensions of the Mantel-Haenszel procedure. J Am Stat Assoc. 1963;58(303):690\u2013700.","journal-title":"J Am Stat Assoc."},{"issue":"4","key":"67_CR15","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. JNCI J Natl Cancer Inst. 1959;22(4):719\u201348.","journal-title":"JNCI J Natl Cancer Inst."},{"issue":"14","key":"67_CR16","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/sim.4780121403","volume":"12","author":"LE Moses","year":"1993","unstructured":"Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary roc curve: data-analytic approaches and some additional considerations. Stat Med. 1993;12(14):1293\u2013316.","journal-title":"Stat Med."},{"issue":"4","key":"67_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1177\/0272989X9301300408","volume":"13","author":"B Littenberg","year":"1993","unstructured":"Littenberg B, Moses LE. Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method. Med Decis Mak. 1993;13(4):313\u201321.","journal-title":"Med Decis Mak."},{"issue":"3","key":"67_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388.","journal-title":"Control Clin Trials."},{"issue":"12","key":"67_CR19","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1002\/1097-0142(19820615)49:12<2470::AID-CNCR2820491210>3.0.CO;2-Y","volume":"49","author":"J-F Boivin","year":"1982","unstructured":"Boivin J-F, Hutchison GB. Coronary heart disease mortality after irradiation for Hodgkin's disease. Cancer. 1982;49(12):2470\u20135.","journal-title":"Cancer."},{"issue":"1","key":"67_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1476-7120-8-8","volume":"8","author":"ME Gianicolo","year":"2010","unstructured":"Gianicolo ME, Gianicolo EAL, Tramacere F, Andreassi MG, Portaluri M. Effects of external irradiation of the neck region on intima media thickness of the common carotid artery. Cardiovasc Ultrasound. 2010;8(1):8.","journal-title":"Cardiovasc Ultrasound."},{"issue":"5","key":"67_CR21","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.ijrobp.2017.03.026","volume":"98","author":"E Hahn","year":"2017","unstructured":"Hahn E, Jiang H, Ng A, Bashir S, Ahmed S, Tsang R, et al. Late cardiac toxicity after Mediastinal radiation therapy for Hodgkin lymphoma: contributions of coronary artery and whole heart dose-volume variables to risk prediction. Int J Radiat Oncol. 2017;98(5):1116\u201323.","journal-title":"Int J Radiat Oncol."},{"issue":"1","key":"67_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1200\/JCO.2006.07.0805","volume":"26","author":"PA Heidenreich","year":"2007","unstructured":"Heidenreich PA, Schnittger I, Strauss HW, Vagelos RH, Lee BK, Mariscal CS, et al. Screening for coronary artery disease after Mediastinal irradiation for Hodgkin\u2019s disease. J Clin Oncol. 2007;26(1):43\u20139.","journal-title":"J Clin Oncol."},{"key":"67_CR23","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1093\/annonc\/8.suppl_1.S115","volume":"8","author":"RT Hoppe","year":"1997","unstructured":"Hoppe RT. Hodgkin\u2019s disease: complications of therapy and excess mortality. Ann Oncol. 1997;8:S115\u20138.","journal-title":"Ann Oncol."},{"issue":"6","key":"67_CR24","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/pbc.22664","volume":"55","author":"G Schellong","year":"2010","unstructured":"Schellong G, Riepenhausen M, Bruch C, Kotthoff S, Vogt J, B\u00f6lling T, et al. Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies. Pediatr Blood Cancer. 2010;55(6):1145\u201352.","journal-title":"Pediatr Blood Cancer."},{"issue":"3","key":"67_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/jnci\/djk029","volume":"99","author":"AJ Swerdlow","year":"2007","unstructured":"Swerdlow AJ, Higgins CD, Smith P, Cunningham D, Hancock BW, Horwich A, et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. JNCI J Natl Cancer Inst. 2007;99(3):206\u201314.","journal-title":"JNCI J Natl Cancer Inst."},{"issue":"3","key":"67_CR26","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.amjcard.2010.09.048","volume":"107","author":"H-R Tsai","year":"2011","unstructured":"Tsai H-R, Gjesdal O, Wethal T, Haugaa KH, Foss\u00e5 A, Foss\u00e5 SD, et al. Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin\u2019s lymphoma treated by Mediastinal radiotherapy with or without Anthracycline therapy. Am J Cardiol. 2011;107(3):472\u20137.","journal-title":"Am J Cardiol."},{"issue":"32","key":"67_CR27","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1200\/JCO.2014.56.7511","volume":"32","author":"LW Jones","year":"2014","unstructured":"Jones LW, Liu Q, Armstrong GT, Ness KK, Yasui Y, Devine K, et al. Exercise and risk of major cardiovascular events in adult survivors of childhood Hodgkin lymphoma: a report from the childhood cancer survivor study. J Clin Oncol. 2014;32(32):3643\u201350.","journal-title":"J Clin Oncol."},{"issue":"6","key":"67_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1182\/blood-2010-04-278796","volume":"117","author":"SM Castellino","year":"2011","unstructured":"Castellino SM, Geiger AM, Mertens AC, Leisenring WM, Tooze JA, Goodman P, et al. Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood. 2011;117(6):11.","journal-title":"Blood"},{"issue":"6","key":"67_CR29","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1182\/blood-2002-02-0634","volume":"100","author":"AK Ng","year":"2002","unstructured":"Ng AK, Bernardo MVP, Weller E, Backstrand K, Silver B, Marcus KC, et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood. 2002;100(6):1989\u201396.","journal-title":"Blood."},{"issue":"7","key":"67_CR30","doi-asserted-by":"publisher","first-page":"555","DOI":"10.4330\/wjc.v6.i7.555","volume":"6","author":"S Kupeli","year":"2014","unstructured":"Kupeli S. Risks and diagnosis of coronary artery disease in Hodgkin lymphoma survivors. World J Cardiol. 2014;6(7):555.","journal-title":"World J Cardiol."}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-020-00067-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-020-00067-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-020-00067-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T19:16:32Z","timestamp":1628104592000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiooncologyjournal.biomedcentral.com\/articles\/10.1186\/s40959-020-00067-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,5]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["67"],"URL":"https:\/\/doi.org\/10.1186\/s40959-020-00067-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-28615\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-28747\/v1","asserted-by":"object"}]},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,5]]},"assertion":[{"value":"12 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"none.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}